Another study showed that acute administration of exenatide was associated with increased hepatic glucose uptake during an oral glucose tolerance test (OGTT) and a reduction in endogenous glucose production, reinforcing the hypothesis of a direct action of GLP-1 on the liver [12]
This means the final product is not reviewed for safety or efficacy the way commercial drugs are
It is important to note that all dosing regimens described here are investigational
Our Role in Metabolic Research Support Retatrutide is being investigated for its interaction with GLP-1, GIP, and glucagon receptors
Most cardiology guidelines suggest continuing DOAC therapy without dose adjustment when adding GLP-1 medications, though individual patient factorskidney function, body weight, bleeding historymay warrant consultation with your prescribing cardiologist
Because GLP1 agonists are becoming more widely used, scientists are now studying an important question: How do these medications affect eye health